Effectiveness of Influenza Vaccine in Preventing Death among Ontario Residents Aged ≥65 Years during 20 Seasons
David K. Shay(National Center for Emerging and Zoonotic Infectious Diseases), Jeffrey C. Kwong(University Health Network), Benjamin J. Ridenhour(Indiana University Bloomington), Michael A. Campitelli(Mount Sinai Hospital)
Cited by 1
Related Papers
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
|New England Journal of Medicine|2018|1.2k
Obesity and Respiratory Hospitalizations During Influenza Seasons in Ontario, Canada: A Cohort Study
|Clinical Infectious Diseases|2011|199
Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe
|The Lancet Infectious Diseases|2022|183
Increased risk of mycobacterial infections associated with anti-rheumatic medications
|Thorax|2015|172
COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021
|MMWR Morbidity and Mortality Weekly Report|2021|167